| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |